CRISIL announced that the business transfer agreement has been completed today, i.e. 02 December 2024 and the sale of Peter Lee Associates (PLA) to CRISIL Irevna Australia (CRISIL Australia) is now effective. The final consideration (Net Asset Value as at date of closing i.e. December 2, 2024) is AUD 451,200. PLA will proceed for deregistration in due course. Both PLA & CRISIL Australia are wholly owned subsidiaries of the Company, based in Australia. Powered by Capital Market - Live News

CRISIL announced that the Board of Directors of the Company at its meeting held on 16 October 2024, inter alia, have recommended the Third Interim dividend of Rs 15 per equity Share (i.e. 1500%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of CRISIL rose 12.87% to Rs 171.55 crore in the quarter ended September 2024 as against Rs 151.99 crore during the previous quarter ended September 2023. Sales rose 10.32% to Rs 811.84 crore in the quarter ended September 2024 as against Rs 735.87 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales811.84735.87 10 OPM %27.5726.05 - PBDT244.51226.81 8 PBT228.53200.31 14 NP171.55151.99 13 Powered by Capital Market - Live News

CRISIL has allotted 140 equity shares under ESOP on 16 October 2024. Powered by Capital Market - Live News

CRISIL will hold a meeting of the Board of Directors of the Company on 16 October 2024.Powered by Capital Market - Live News